PEANUT ALLERGY
Clinical trials for PEANUT ALLERGY explained in plain language.
Never miss a new study
Get alerted when new PEANUT ALLERGY trials appear
Sign up with your email to follow new studies for PEANUT ALLERGY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough trial tests shot to help kids eat foods They're allergic to
Disease control CompletedThis study tested whether an injection called omalizumab, alone or combined with gradually eating small amounts of problem foods (oral immunotherapy), could help people with multiple food allergies. It involved 471 children and adults allergic to peanut and at least two other foo…
Matched conditions: PEANUT ALLERGY
Phase: PHASE3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Could grocery store fiber help kids overcome peanut allergy?
Disease control CompletedThis study tested whether adding a common dietary fiber supplement to standard peanut allergy treatment helps children better tolerate small amounts of peanut. Researchers enrolled 20 children aged 4-17 to see if the fiber reduced treatment side effects and improved outcomes by p…
Matched conditions: PEANUT ALLERGY
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Peanut doses tested to tame Kids' allergies
Disease control CompletedThis study tested whether giving children with peanut allergy small, increasing amounts of peanut protein could help them build tolerance. 44 children were randomly assigned to receive either a 150mg or 300mg daily maintenance dose. The main goal was to see how many children coul…
Matched conditions: PEANUT ALLERGY
Phase: NA • Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
First human test for new peanut allergy drug begins
Disease control CompletedThis was an early safety study to test a new drug called IGNX001 for peanut allergy. It involved 32 adults and older teenagers with confirmed peanut allergies. The main goal was to see if single, gradually increasing doses were safe and how the drug behaved in the body, not to tr…
Matched conditions: PEANUT ALLERGY
Phase: PHASE1 • Sponsor: IgGenix Australia Pty Ltd • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC